Published price vs quote-only
Gala vs Wellorithm: Which One Publishes Its Price? (2026)
Compare Gala and Wellorithm on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.7 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Gala and Wellorithm both prescribe GLP-1 medication online, take payment directly from the patient and ship to the door. That is where the overlap stops.
One of these programs can be evaluated before you start it and one cannot. Gala lists From $249/mo, as low as $179/mo on longer plans; with Wellorithm, pricing is not published; you receive a quote only after completing the intake quiz.
This comparison works from what each provider publishes: the entry price, what it becomes at month two, the medication actually dispensed, and what is bundled rather than billed. Every figure traces back to the provider's own published material, and the missing ones stay missing.
The short answer
- Easier to price in advance
- Gala — From $249/mo, as low as $179/mo on longer plans. The other side quotes after intake, so a like-for-like total is not available before you apply.
- Most support for the money
- Gala — Provider check-ins and dose monitoring included.
- Fastest route to a first shipment
- Wellorithm — 2-minute eligibility quiz, then medication shipped to your home.
- Most support included
- Gala — Provider check-ins and dose monitoring included.
Side-by-side comparison
Nothing in this table is our estimate. Where a provider does not publish something, the cell says so.
| Gala | Wellorithm | |
|---|---|---|
| Advertised price | From $249/mo, as low as $179/mo on longer plans | Priced after the eligibility quiz |
| Rate after promotions | $249/mo | not published before intake |
| Pricing structure | Cheaper per month the longer you commit | Quoted only after intake |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Published upfront | Quote only, after intake |
| Payment options | Card only, no financing published | Card only, no financing published |
| Shipping | Home delivery | Medication shipped to your home |
| Support model | Provider check-ins included | No coaching program stated |
| Tirzepatide | Not published | Not published |
| Patient reviews | 2,870 | 3,240 |
| eRxDoctor score | 7.7/10 | 7.5/10 |
Cost over a full course of treatment
The advertised rate answers the wrong question. Here is what each one costs across a realistic course of treatment, on published pricing.
| Gala | Wellorithm | |
|---|---|---|
| First month | $249 | Not published |
| Months 2 onward | $249/mo | Not published |
| 6-month total | $1,494 | Not computable |
| 12-month total | $2,988 | Not computable |
| Best published plan | longer-term plan at $179/mo — $2,148/yr | No multi-month discount published |
A like-for-like annual total is not available for Wellorithm: pricing is not published; you receive a quote only after completing the intake quiz. Treat any comparison that quotes one as an estimate someone else has made for you.
One publishes a price. One does not.
With Gala the arithmetic is available in advance — From $249/mo, as low as $179/mo on longer plans, on cheaper per month the longer you commit terms — so it can be compared against anything else on the market.
Wellorithm withholds the figure until 2-minute eligibility quiz is complete — pricing is not published; you receive a quote only after completing the intake quiz. Whatever the reason, it moves the price conversation to after your commitment rather than before it.
The workaround is straightforward: complete Wellorithm's assessment, get the quote, and then price it against Gala's published $249/mo before agreeing to anything.
A closer look at Gala
Gala GLP-1 is a direct-pay telehealth platform offering compounded semaglutide and tirzepatide with provider check-ins and home delivery.
The process is fully online, no in-office visits, then home delivery. On money, expect cheaper per month the longer you commit — published upfront.
What continues after the first shipment: provider check-ins and dose monitoring included. Formulary: compounded semaglutide and compounded tirzepatide.
Gala pros
- Provider check-ins and dose monitoring included
- Direct-pay model, no insurance or prior authorizations needed
- Fully online, no in-office visits required
Gala cons
- Higher entry price than several compounded competitors
- Lower long-term pricing requires a multi-month commitment
Set beside Wellorithm, the thing to weigh: the entry price sits above most compounded competitors unless you commit to a longer term.
Wellorithm: what you are buying
Wellorithm positions itself on licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin. Take the 2-Minute Quiz to Check Your Eligibility
Getting started means 2-minute eligibility quiz, after which medication shipped to your home. Pricing runs on a quoted only after intake basis, quote only, after intake.
Virtual consultations with licensed clinicians. The formulary covers compounded semaglutide and compounded tirzepatide.
Wellorithm pros
- Licensed clinicians in all 50 states, broader coverage than many smaller platforms
- Both compounded semaglutide and tirzepatide available
- Fully virtual consultations with medication shipped to your home
- No insurance pre-authorization required
Wellorithm cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Pricing is not published, you only get a quote after completing the intake quiz
- Smaller, less-established platform with limited public reviews
Where it gives ground to Gala: a smaller platform with no published price and limited public review volume.
Which one fits which patient
Choose Gala if:
- the feature you would actually use: a direct-pay model with dose monitoring included rather than sold as an add-on
- the level of clinical contact suits you: provider check-ins and dose monitoring included
- you want the full price in front of you before completing an intake
- you are willing to commit for a term in exchange for a lower effective rate (longer-term plan at $179/mo)
Choose Wellorithm if:
- delivery works the way you want it to: medication shipped to your home
- the level of clinical contact suits you: virtual consultations with licensed clinicians
- you want to start on their timeline: 2-minute eligibility quiz
- you are in a state where GLP-1 telehealth coverage is patchy
The compromises on both sides
On price. Only Gala publishes a rate you can plan against (From $249/mo, as low as $179/mo on longer plans). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On predictability. The pricing structures differ (cheaper per month the longer you commit versus quoted only after intake), and structure, not headline rate, determines the twelve-month bill.
On access. Gala advertises fully online, no in-office visits and home delivery; Wellorithm advertises 2-minute eligibility quiz and medication shipped to your home. Coverage differs too — not published against all 50 states — which decides the question before price does if you are in a restricted state.
On medication. Gala covers compounded semaglutide and compounded tirzepatide; Wellorithm covers compounded semaglutide and compounded tirzepatide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
The clinical evidence, separated from the marketing
Weight loss percentages quoted in telehealth marketing come from trials neither Gala nor Wellorithm ran. Here is the source material, and what regulators say alongside it.
The FDA is explicit that a compounded preparation has not been reviewed for safety, effectiveness or manufacturing quality the way an approved drug has, per FDA.
The rules governing which pharmacies may compound, and under what conditions, sit in sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, per FDA.
Use it as the floor for the conversation with whichever prescriber you end up with, rather than as a reason to pick one platform over the other.
Gala vs Wellorithm: common questions
Which is cheaper to start, Gala or Wellorithm?
Only Gala publishes a first-month figure (From $249/mo, as low as $179/mo on longer plans). The other quotes after intake, so a starting-cost comparison is not available in advance.
Which has more patient reviews, Gala or Wellorithm?
Wellorithm, with 3,240 against 2,870. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do Gala or Wellorithm take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Are Gala and Wellorithm legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Gala operates on cheaper per month the longer you commit with pricing published upfront, Wellorithm on quoted only after intake, quote only, after intake. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
How fast can I start with Gala compared with Wellorithm?
Gala advertises fully online, no in-office visits, with home delivery. Wellorithm advertises 2-minute eligibility quiz, with medication shipped to your home. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Gala leads on a direct-pay model with dose monitoring included rather than sold as an add-on; Wellorithm leads on licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- Gala vs RefillsBudget vs premium
- Gala vs EmbodyBudget vs premium
- Wellorithm vs TMatesPublished price vs quote-only
- MedVi vs WellorithmPublished price vs quote-only
- Directmeds vs MeasuredPublished price vs quote-only
- Directmeds vs Sprout HealthPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Gala or Wellorithm, and does not sell treatment. Read our ranking methodology.